TABLE 3.
Univariate correlations between progranulin mRNA expression in visceral and subcutaneous adipose tissue and measures of obesity, insulin sensitivity, and parameters of inflammation (n = 55)
| r | P value | Adjusted for BMI
|
||
|---|---|---|---|---|
| r | P value | |||
| Visceral progranulin mRNA | ||||
| Serum progranulin | 0.27 | <0.01 | 0.17 | 0.03 |
| CRP | 0.25 | <0.01 | 0.18 | 0.02 |
| MCP-1 | 0.18 | 0.03 | 0.06 | 0.6 |
| Visceral fat area | 0.46 | <0.001 | 0.28 | <0.01 |
| BMI | 0.41 | <0.01 | — | — |
| Body fat (%) | 0.39 | <0.01 | 0.04 | 0.7 |
| Visceral macrophage number | 0.62 | <0.001 | 0.45 | <0.001 |
| HDL cholesterol | −0.35 | <0.001 | −0.12 | 0.1 |
| GIR | −0.31 | <0.01 | −0.11 | 0.1 |
| Subcutaneous progranulin mRNA | ||||
| Subcutaneous macrophage number | 0.6 | <0.001 | 0.38 | <0.001 |
| CRP | 0.34 | <0.001 | 0.22 | 0.01 |
GIR, glucose infusion rate during the steady state of a euglycemic-hyperinsulinemic clamp.